LUNG earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E -0.93. Updated 2026-07-23.
Pulmonx (LUNG) Research Hub
Pulmonx (LUNG) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 1.85 USD (-6.57%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.93, market cap 0.05B. This hub links to the full technical, earnings and options research available for LUNG.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.85 USD (-6.57%) |
| 52-week range | 1.17 USD – 2.59 USD |
| Trend regime | Range |
| 14-day RSI | 43.4 (Bearish) |
| Trailing P/E | -0.93 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for LUNG
Covered Call on LUNG: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LUNG: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LUNG: how it works, illustrative setup around the real 1.85 USD price, max profit/loss, breakeven and when to use it. Educational.
LUNG technical analysis: range, last 1.85 USD, RSI 43.4, 52w range 1.17 USD–2.59 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LUNG in?
Pulmonx (LUNG) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is LUNG in an uptrend or downtrend?
As of 2026-09-11, LUNG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LUNG's trailing P/E ratio?
LUNG's trailing P/E is -0.93, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does LUNG next report earnings?
LUNG is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of -0.28 USD.